Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,628 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,472
Recruiting: 1,283
Ph III recruiting: 130
Growth YoY: +4.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,642)

clinicaltrialsPublishedShowing 1,101–1,150 of 1,329 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02024815	Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma.	unknown	Phase 3	100	Lithuanian University of Health SciencesOTHER	1	Dec 31, 2013	clinicaltrials
NCT02023671	IMMUNOPHENOTYPE ROLE IN THE EVALUATION OF CLINICAL RESPONSE	unknown	—	70	Azienda Ospedaliera San Giovanni BattistaOTHER	0	Dec 30, 2013